The PDTOs were positive for subtype-specific markers; i.e., TTF-1 and CK-7 for adenocarcinomas, p63 and CK5/6 for squamous cell carcinomas, and CD56 and synaptophysin for small-cell lung cancer [14]. This evidence concerns the gene NCAM1 and adenocarcinoma.